CSL112 Increases Plasma Cholesterol Efflux Capacity and Reduces Erythrocyte Membrane Cholesterol Content in Blood Samples from Patients with Sickle Cell Disease

Autor: Didichenko, Svetlana *, Navdaev, Alexey *, Saxenhofer, Moritz *, Graeter, Stefanie *, Schaub, Alexander *, Rovo, Alicia, Kato, Gregory J, Kingwell, Bronwyn *
Zdroj: In Blood 15 November 2022 140 Supplement 1:2528-2529
Databáze: ScienceDirect